We produce research based on our field experience. Our studies have changed clinical practice worldwide.
This week, we reflect on MSF Scientific Days 2016. The two-day conference was a huge success, watched by 10,013 people in 120 countries across the world. We would like to thank everyone that participated – both in London and online. If you have any suggestions for what you’d like to see at the event next year let us know (firstname.lastname@example.org). Don’t forget it is MSF Scientific Day South Asia this Saturday (28 May) – everything will be livestreamed so be sure to tune in!
An MSF study in The Paediatric Infectious Disease Journal assesses paediatric access and continuity of HIV care before the start of antiretroviral therapy (ART) in sub-Saharan Africa. In American Journal of Infection Control, MSF introduces an antibiotic stewardship programme (ASP) in a hospital in Jordan for patients with chronic infections, and in International Health, MSF assesses the use of symptom screening questionnaires to improve timely diagnosis of active pulmonary TB among migrants in Italy.
A comment in The Lancet discusses the history of yellow fever, in light of the current outbreak in Angola and DRC, and The NEJM examines acute HIV-1 infections to better support the development of treatment strategies.
Lastly, Research for Health in Humanitarian Crises (R2HC) are opening their Fourth Call for Proposals on June 1, and will make up to £3million available for research addressing public health within humanitarian contexts.
Paed Inf Dis J • Research ***MSF Author***: Pediatric access and continuity of HIV care before the start of antiretroviral therapy in sub-Saharan Africa
Int J Epidemiol • Research ***MSF Author***: Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa
The Lancet • Correspondence: Trial size, HIV pre-exposure prophylaxis, and breastfeeding
The Lancet • Correspondence: Trial size, HIV pre-exposure prophylaxis, and breastfeeding – Authors' reply
The Lancet HIV • Article: Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial and comment
PLOS Medicine • Article: Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola
The Lancet • Comment: Yellow fever: the resurgence of a forgotten disease
Int Health • Article**MSF Authors**: Lessons learnt from TB screening in closed immigration centres in Italy
Maternal and Child Health
The Lancet • Comment: Learning Together to improve children's health
The Lancet • Comment: Late maternal deaths: a neglected responsibility
Health in a Humanitarian Context
The Lancet • World Report: Helping Colombia's landmine survivors
JAMA Op • Comment: Zika Virus Infection and the Eye
PLOS NTDs • Article: A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control
The BMJ • News: Obama calls on Congress to fully fund Zika response
PLOS Medicine • Editorial: Health Research and the World Humanitarian Summit—Not a Thousand Miles Apart
AJIC • Article**MSF Author**: Introducing an antibiotic stewardship program in a humanitarian surgical hospital
The Economist • Article: The grim prospect
The Lancet Inf Dis • Comment: Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance
Malaria Journal • Article: A significant association between deltamethrin resistance, Plasmodium falciparum infection and the Vgsc-1014S resistance mutation in Anopheles gambiae highlights the epidemiological importance of resistance markers
Compiled by: Holly Baker, Jeffrey Hau, & Kim West
Médecins Sans Frontières (MSF) UK
MSF-authored article list assistance:
Frances Williams, Patricia Kahn
Médecins Sans Frontières (MSF) USA
If you are unable to access any of these articles please contact Kaai Meier-de Kock (email@example.com) at the MSF-DE Library and Research Centre or Aline Raymond (firstname.lastname@example.org) at OCB's IDC (Information and Documentation Centre) who will aim to send you the article within 48 hours.